TP53 and breast carcinoma: For example, the test has been used with fresh frozen breast tumor tissue in prospective clinical studies to demonstrate prognostic value of TP53 mutation status [7–8] and that treatment response correlates with TP53 mutation status in early stage breast cancer [9].